Your Science is Ready.
Let's Make it Commercial.

High Touch Group is the commercialization and marketing partner for life sciences tools and services, diagnostics, medtech, biotech, CROs, and CDMOs.

We help science-led companies enter markets, generate pipeline, grow revenue, and raise capital. We can strengthen an existing team, take responsibility for specific marketing functions, or operate most of marketing when the company needs greater speed, capacity, or accountability.

$21M
IN REVENUE FROM ONE CAMPAIGN
125+
SCIENCE COMPANIES SERVED
$1B+
RAISED WITH OUR SUPPORT
~12
CLIENTS PER YEAR, BY DESIGN

What We
Help You Do

Every engagement starts with a commercial problem. Here’s what our clients hire us to solve.

01 / 06

Get Your Story Right

Clarify the positioning, messaging, and commercial story your buyers, investors, partners, and other stakeholders need to understand.

LEARN MORE
02 / 06

Run or Strengthen Marketing

Bring us in alongside an established team, give us responsibility for the functions that need work, or have HTG operate most of marketing.

LEARN MORE
03 / 06

Strengthen Commercial Capability

Help commercial teams understand the market, reach the right buyers, and turn technical differentiation into a stronger commercial position. 

LEARN MORE
04 / 06

Get Discovered

Make it easier for buyers, partners, investors, search engines, and AI-driven research tools to find and understand the company. 

LEARN MORE
05 / 06

Produce Scientific Events

Use conferences and events to create meaningful commercial opportunities before, during, and after the event. End-to-end conference production, trade shows, VIP events, and symposia.

LEARN MORE
06 / 06

Raise Capital

Develop the positioning, market story, investor materials, and commercial evidence needed to communicate the opportunity clearly.

LEARN MORE

Who We Serve

We work in diagnostics, medtech, and biotech, and with the companies that serve them.

Diagnostics & IVD

IVD developers, point-of-care manufacturers, clinical lab tools, and molecular diagnostics companies.

Learn More

MedTech & Medical Devices

Medical device companies, wearables, digital health hardware, and surgical technology.

Learn More

Biotechnology

Therapeutics-stage biotechs, CROs, contract services, and supporting technologies.

Learn More

Life Sciences Tools, Services & CROs

Reagent and instrument manufacturers, CROs, CDMOs, biospecimen providers, laboratory services, scientific software companies, and other businesses selling products and services into research, biopharma, diagnostics, and clinical markets.

Learn More

Marketing That
Keeps Up With the
Value Creation Plan

In PE-backed companies, marketing must support the commercial plan with the speed and accountability the company's growth objectives require.

HTG can work alongside the existing team, take responsibility for specific marketing functions, or operate most of marketing. We also support post-acquisition marketing integration, measurement and reporting, and the information management and boards need to understand what marketing is producing.

Services for Private Equity & Portfolio Companies
01

Augment the Team

Add capacity and specialized expertise.

02

Own Specific Functions

Take responsibility for the areas that need stronger execution.

03

Run Most of Marketing

Operate the function with company leadership setting commercial priorities and appropriate approvals.

How
We Work

We work as an embedded partner for companies with ongoing commercial and marketing needs. The engagement structure adapts to where you are. The depth doesn't.

Our Preferred Model

Retainer

A 12-month engagement at a fixed monthly rate. We operate as an embedded extension of your commercial and marketing function. We know your science, your market, your competitors, and your goals. We build on that knowledge month over month. The briefs get shorter. The strategy gets sharper. Momentum builds. Retainer clients see better outcomes across the board. We're transparent about this because it's the most useful thing we can tell you before you decide how to engage.

Learn More
Fixed Fee, Defined Scope

Projects

Some engagements have a clear beginning and end: a market entry strategy, a scientific conference, a product launch, a pitch deck, sales team training, a competitive intelligence report. We scope it, price it, and deliver it. Projects are also a natural first step for companies that want to see how we work before committing to a longer engagement.

Learn More

Building your commercial story from the ground up?

Our Commercial Readiness Sprints are 30- to 60-day fixed-fee engagements designed for early-stage founders.

Learn About Sprints

Commercial
Readiness Sprints

You're pre-commercial, pre-Series A, or somewhere in between. Your science is solid. Your commercial story isn't landing yet.

Our Commercial Readiness Sprints are 30- to 60-day engagements that get your positioning, messaging, and investor-facing assets where they need to be. All are fixed fee, senior-led, and include direct access to Elizabeth Chabe, HTG CEO and the bestselling author of The Giant's Ladder: The Science Professional's Blueprint for Marketing Success.

[01]

Messaging
Ready Sprint

30 DAYS
$6,000

Investor-ready messaging, a core strategic asset, and a written brief with next steps.

Learn More
[02]

Pitch
Ready Sprint

45 DAYS
$10,000

Everything in Messaging Ready, plus a fully refined investor pitch deck and a curated VC targeting list with outreach strategy.

Learn More
[03]

Investor
Ready Sprint

60 DAYS
$15,000

Everything in Pitch Ready, plus an expanded VC and partner targeting plan and a founder-ready channel and marketing plan.

Learn More

All Sprints include a direct strategy session with Elizabeth Chabe, CEO of High Touch Group and bestselling author of The Giant's Ladder.

Elizabeth Chabe, founder and CEO of High Touch Group
Elizabeth Chabe, founder and CEO of High Touch Group

Meet Elizabeth Chabe,
HTG CEO

Elizabeth Chabe (MBA) is the founder and CEO of High Touch Group and the author of The Giant’s Ladder: The Science Professional’s Blueprint for Marketing Success. She has spent her career at the intersection of science and commercial strategy, working with diagnostics and medtech founders, advising VC firms, and consulting for national health agencies. Since 2018, she has served as a governor-appointed director of the Maine Venture Fund, where she advises portfolio companies and helps direct strategic investments.

The definitive guide for scientists and founders who need to think like marketers.

Get the Book
The Giant's Ladder
Our clients have been featured in